Drug Trial Radar · NCT04712032
Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates
Last checked: Nov 19, 2026Latest source record: Jan 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
978
Planned (sponsor's estimate)
Start
Jul 1, 2020
Primary completion
Jul 1, 2022
Study completion Oct 1, 2022
Sponsor
- Lead sponsor
- Leiden University Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medical Center Haaglanden; Catharina Ziekenhuis Eindhoven; Haga Hospital; Jeroen Bosch Ziekenhuis; Amphia Hospital; Alrijne Hospital; IJsselland Hospital
- First posted
- Jan 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Anastomotic leakage (AL) is one of the major complications after gastrointestinal surgery. Compromised tissue perfusion at the anastomosis site increases the risk of AL. Indocyanine green (ICG) combined with fluorescent near infrared imaging has proven to be a feasible and reproducible application for real-time intraoperative quantification of the tissue perfusion and cohort studies showed reduced leakage rate. Unfortunately, these studies were not randomized. Therefore, we propose a nationwide randomized controlled trial to identify the value of ICG for AL in colorectal anastomosis.
Conditions
- Colo-rectal Cancer
- Crohn Disease
- Resectable Colorectal Carcinoma
Interventions
ICG-guided bowel perfusion assessmentDrug
ICG will be injected prior to anastomosis creation, to assess perfusion status of the bowel.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 90-days Anastomotic Leakage (AL) rateTime frame: 90 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Leiden University Medical Center
Leiden, South Holland, Netherlands · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.